Finance

Lists
ESTA:NASDAQ
Establishment Labs Holdings Inc
$59.71
+0.90%
(+0.53) 1D
Oct 19, 11:12:39 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ESTA...
Open
$60.61
High
$60.61
Low
$59.04
Mkt. cap
1.78B
Avg. vol.
357.17K
Volume
38.29K
52-wk high
$97.40
52-wk low
$47.00
EPS
-$1.30
Beta
1.06
Shares outstanding
29.80M
No. of employees
56
Open
$60.61
High
$60.61
Low
$59.04
Mkt. cap
1.78B
Avg. vol.
357.17K
Volume
38.29K
52-wk high
$97.40
52-wk low
$47.00
EPS
-$1.30
Beta
1.06
Shares outstanding
29.80M
No. of employees
56
News stories
From web sources and news partners
About Establishment Labs Holdings Inc
CEO-
Employees56
Founded2004
Headquarters-
SectorMedical device
Websiteestablishmentlabs.com
Analyst ratings
Based on 8 analysts giving stock ratings to ESTA in the past 3 months
Strong buy
Buy
8
Hold
0
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for ESTA in the last 3 months.
Highest
Current $59.71
$117.00 (+95.95%)
Average
$99.63 (+66.86%)
Lowest
$85.00 (+42.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Matson
Needham
Buy
Reiterated
$95.00
+59.1%
10/15/2026
Joseph Federico
Stifel Nicolaus
Buy
Initiated
$85.00
+42.4%
10/15/2026
Jonathan Block
Stifel Nicolaus
Buy
Initiated
$85.00
+42.4%
10/15/2026
Unknown Analyst
Stifel Nicolaus
Buy
Initiated
$85.00
+42.4%
10/14/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
$105.00
+75.8%
10/06/2026
Sam Eiber
BTIG
Buy
Reiterated
$103.00
+72.5%
10/05/2026
Josh Jennings
TD Cowen
Buy
Maintained
$117.00
+95.9%
10/05/2026
Matthew Taylor
Jefferies
Buy
Reiterated
$105.00
+75.8%
09/08/2026
Joanne Wuensch
Citi
Buy
Upgraded
$92.00
+54.1%
08/13/2026
Allen Gong
J.P. Morgan
Buy
Maintained
$95.00
+59.1%
08/10/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
$105.00
+75.8%
07/15/2026
Mason Carrico
Stephens
Buy
Reiterated
$90.00
+50.7%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
53.78M
64.62M
59.88M
67.54M
Cost of goods sold
16.09M
19.08M
17.54M
19.83M
Cost of revenue
16.09M
19.08M
17.54M
19.83M
Research and development expenses
4.56M
5.43M
5.24M
5.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37.17M
44.03M
43.60M
46.90M
Operating expense
41.72M
49.46M
48.85M
52.00M
Total operating expenses
57.81M
68.55M
66.39M
71.83M
Operating income
-4.02M
-3.93M
-6.51M
-4.29M
Other non operating income
-142.00K
225.00K
779.00K
246.00K
EBT including unusual items
-10.72M
-11.92M
-13.09M
-11.74M
EBT excluding unusual items
-10.72M
-11.92M
-13.09M
-11.74M
Income tax expense
424.00K
-9.30M
288.00K
6.00K
Effective tax rate
-3.95%
78.05%
-2.20%
-0.05%
Other operating expenses
-
-
-
-
Net income
-11.15M
-2.62M
-13.38M
-11.75M
Net profit margin
-20.72%
-4.05%
-22.35%
-17.39%
Earnings per share
-0.38
-0.09
-0.40
-0.32
Interest and investment income
48.00K
34.00K
26.00K
36.00K
Interest expense
-6.20M
-7.24M
-7.09M
-7.03M
Net interest expenses
-6.16M
-7.21M
-7.06M
-7.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.64M
-1.44M
-4.03M
-1.87M
Gain or loss from assets sale
64.00K
97.00K
47.00K
66.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps